Patent · US Active

Antibodies to PfGARP kill Plasmodium falciparum malaria parasites and protect against infection and severe disease

US11692026B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 11, 2021
Grant dateJul 4, 2023
Priority date
Expiry dateMay 12, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods, compositions and kits for preventing and treating malaria. Also included herein are kits for preventing and treating malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.